Assessment of the Quality of the Treatment of Atopic Dermatitis of the Face

Abstract

this article attempts to reveal the main reasons for the effectiveness and safety of the use of comfodermK cream (methylprednisolone aceponate 0.1%) and tacropic ointment 0.03% (tacrolimus 0.03%) for the treatment of manifestations of atopic dermatitis on the face. To carry out scientific work, the author evaluated the results of treatment was carried out in 12 patients, aged 6 to 13 years, with a diagnosis of atopic dermatitis, the childhood period was moderate. The problem in question is still little studied, therefore, requires more thorough research.